相关实验视频

Updated: Jan 18, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

在患有初级玻璃眼瘤的患者中,内源性眼内干扰素β的较低水平

Archana Padmanabhan Nair^1,2, Praveen Machiraju¹, Sushma Tejwani³

¹GROW Research Lab, Narayana Netralaya Foundation, Bangalore, India.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

|June 9, 2025

概括

玻璃眼病患者在水性幽默和尾管网中具有较低的干扰素β (IFN-β) 水平,这表明它具有神经保护作用. 这一发现表明了基于IFN-β的光瘤预后和治疗的潜力.

科学领域:

眼科医生眼科眼科
神经科学是一个神经科学.
免疫学免疫学免疫学

背景情况:

玻璃眼瘤是一种神经退行性视神经疾病,与视内压升高 (IOP) 相关,由状眼网 (TM) 纤维化引起.
干扰素β (IFN-β) 是一种细胞因子,具有已知的神经保护和抗纤维性质.

研究的目的:

在被诊断为初级绿眼瘤的患者中调查IFN-β的眼内水平.
探索IFN-β在绿眼病原和进展中的潜在作用.

主要方法:

从初级青光眼患者 (POAG和PACG) 和对照对象收集水性幽默 (AqH) 和TM样本.
在AqH中IFN-β水平使用ELISA量化.
在TM组织中IFN-βmRNA表达通过定量PCR进行了评估.

主要成果:

与对照组相比,青光眼患者,特别是POAG患者的AqH-IFN-β水平显著降低.
在POAG患者中,较低的AqH-IFN-β水平与较差的视野指数和减少的视网膜神经纤维层厚度相关.
在低于最佳的IOP控制的青光眼患者中,TM-IFN-β mRNA表达较低.

结论:

减少的IFN-β在青光眼患者的水性幽默和状网状网络表明神经保护和抗纤维功能.
IFN-β水平可能作为青光眼的预后标志物.
IFN-β 是一种潜在的治疗目标,用于治疗眼.

关键词:

如果是IFN-β,那么它是什么?含有水性幽默的水性幽默玻璃眼 glaucoma 玻璃眼玻璃眼玻璃眼玻璃眼干扰素ββ是一种干扰素.状网状网状网状网状网状网状网.

更多相关视频

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

相关概念视频

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...